Key result
NSTEMI is linked to ~282% greater one-year mortality risk among post-ACS patients.
Why the study?
Information about post-ACS survival has been mostly short-term or based on specialized cardiology referral centers, lacking data from community, non-specialized hospitals.
Cohort (n=964)
No
Hazard Ratio: 3.82 (95% CI 2.21–6.6)
In a community hospital setting in Brazil, post-ACS patients had a 12% one-year mortality rate, with age, ACS subtype, and diabetes being strong independent predictors of poor survival.
No takes yet. Share an insight, caveat, or question.
12% one-year post-ACS mortality in community hospitals signals need for targeted risk reduction; extends survival data beyond specialized centers.
Santos et al. (2015) conducted a cohort in Acute coronary syndrome (ACS) (n=964). Baseline characteristics and ACS subtypes (e.g., NSTEMI, STEMI, diabetes) vs. Reference baseline characteristics was evaluated on All-cause mortality at one year (HR 3.82, 95% CI 2.21-6.60). In 964 post-ACS patients, the one-year mortality rate was 12.0%, with NSTEMI (HR 3.82; 95% CI 2.21-6.60), STEMI, age, and diabetes acting as independent predictors of all-cause mortality.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: